Über uns
Dr Ezhil is an experienced Oncology Consultant. She led the implementation of the stereotactic ablative body radiotherapy (SABR) lung service at the Royal Surrey County Hospital (RSCH) in January 2012 and has treated over 150 patients to date. She is currently the SABR lead for the treatment of oligometastases at RSCH and delivers SABR across all cancer sites and will consider patients with three or fewer metastases in lung, liver, spine, bone, adrenal or lymph node from any solid tumour; using her skill advanced radiotherapy techniques to treat advanced disease.
Dr Ezhil started her post as a substantive consultant in clinical oncology in November 2009, specialising in the management of lung cancer and lymphoma.
In addition to her practice, Dr. Ezhil completed a research fellowship in advanced technical radiotherapy at the University of Texas MD Anderson Cancer Centre, Houston, Texas, studying the various methods of managing respiratory motion including 4DCT, respiratory gating and other techniques of IGRT. She also gained clinical experience in SABR and had the benefit of learning the indications and benefits of proton beam therapy.
Dr Ezhil has attended the Stereotactic Body Radiation Therapy Training Programme held at UT Southwestern Medical Centre, Dallas, Texas under the leadership of Timmerman in December 2011 and the SBRT Symposium 2014 held in Amsterdam organised by the Dutch Society of Radiation Oncology in December 2014 to further improve her SABR skills.
She attends American Society for Radiation Oncology (ASTRO) and other national and international conferences on SABR regularly to maintain collaboration with experts in the field of stereotactic radiotherapy and to keep up-to-date with the latest developments and issues in SABR treatments.
Continuing with her passion and interest in research, Dr. Ezhil has has published numerous original articles in oncology journals and presented at national and international meetings.
Diseases, Medical Tests and TreatmentsImage-guided radiotherapy (IGRT)
Radiotherapy
Stereotactic ablative radiotherapy (SABR)
Lung Cancer
Lymphoma
Oligometastatic disease of the lung, liver, spine, bone, adrenal or lymph node from any solid tumour
Dr Ezhil started her post as a substantive consultant in clinical oncology in November 2009, specialising in the management of lung cancer and lymphoma.
In addition to her practice, Dr. Ezhil completed a research fellowship in advanced technical radiotherapy at the University of Texas MD Anderson Cancer Centre, Houston, Texas, studying the various methods of managing respiratory motion including 4DCT, respiratory gating and other techniques of IGRT. She also gained clinical experience in SABR and had the benefit of learning the indications and benefits of proton beam therapy.
Dr Ezhil has attended the Stereotactic Body Radiation Therapy Training Programme held at UT Southwestern Medical Centre, Dallas, Texas under the leadership of Timmerman in December 2011 and the SBRT Symposium 2014 held in Amsterdam organised by the Dutch Society of Radiation Oncology in December 2014 to further improve her SABR skills.
She attends American Society for Radiation Oncology (ASTRO) and other national and international conferences on SABR regularly to maintain collaboration with experts in the field of stereotactic radiotherapy and to keep up-to-date with the latest developments and issues in SABR treatments.
Continuing with her passion and interest in research, Dr. Ezhil has has published numerous original articles in oncology journals and presented at national and international meetings.
Diseases, Medical Tests and TreatmentsImage-guided radiotherapy (IGRT)
Radiotherapy
Stereotactic ablative radiotherapy (SABR)
Lung Cancer
Lymphoma
Oligometastatic disease of the lung, liver, spine, bone, adrenal or lymph node from any solid tumour
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Muthuveni Ezhil
Ausbildung & Training
-
2009–2015 MD · Medicine and Surgery
-
2015–2019 Residency · Onkologie
-
2019–2020 Fellowship · Subspecialty training
Karriere & Anstellungen
-
2019-09–2020-08 Junior consultant
Lizenzen & Versicherung
Medizinische Lizenzen
GB — Organización Médica Colegial de España (OMC)
Facharztzertifikate
European Board of Onkologie
Berufshaftpflichtversicherung:
HDI Global · 3,000,000 EUR Deckung · No claims on file
Durchgeführte Verfahren
| Verfahren | Code | Lebenszeit-Anzahl |
|---|---|---|
| GP consultation | 99213 | 1,653 |
| Annual physical exam | 99395 | 1,947 |
| Vaccination administration | 90471 | 1,043 |
| Minor procedure (skin) | 17110 | 1,908 |
Leistungen & Preise
| Leistung | Dauer | Modalität | Preis |
|---|---|---|---|
| New patient consultation (60m) | 60 Min. | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 Min. | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 Min. | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 120 Min. | in_clinic | 720.00 EUR |
Praxis, Team & in der Praxis
Videos
Forschung & Publikationen
h-Index: 8 · i10: 8
-
Outcomes of Onkologie in adults — a multi-centre cohort
DOI: 10.2053/euroclin.2025.0 · PMID: 38806299 · zitiert von 37
-
European registry analysis of Onkologie outcomes
DOI: 10.4957/euroclin.2024.1 · PMID: 30918861 · zitiert von 87
-
Outcomes of Onkologie in adults — a multi-centre cohort
DOI: 10.9162/euroclin.2023.2 · PMID: 35040091 · zitiert von 129
-
European registry analysis of Onkologie outcomes
DOI: 10.1026/euroclin.2022.3 · PMID: 32362645 · zitiert von 35
Eingeladene Vorträge
- Practical updates in Onkologie European Annual Congress (Onkologie) · Vienna · 2024 · invited
- Single-centre experience in Onkologie National Society Meeting · Guildford · 2023 · oral abstract
Auszeichnungen & Mitgliedschaften
Auszeichnungen
- 🏆 Top-rated Onkologie — Guildford · EuroClinics Patient Choice · 2025 · regional
Gesellschaftsmitgliedschaften
- WONCA Europe — Family Doctors — Member · Seit 2020
- national college of family doctors — Member · Seit 2020
- European Union of Medical Specialists (UEMS) — Member · Seit 2020
Artikel dieses Arztes
- Patient education Patient guide to Onkologie
- Awareness When should you see a onkologie?
Für internationale Patienten
- Koordinator
- Patient liaison · dr.muthuveni.ezhil@euroclinics.example
Standort
1 TagPatientenbewertungen
Teilen Sie Ihre Erfahrung — Helfen Sie anderen Patienten, den richtigen Arzt zu finden. Bewertung schreiben →
Aktuelle Bewertungen
-
★★★★★ ✓ Verifiziert Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verifiziert Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verifiziert Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.